Trials / Completed
CompletedNCT01032174
Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 123 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare compliance between patients with Acute Bacterial Sinusitis (ABS) treated with Azithromycin SR 2.0 g single dose orally and those treated with Amoxiclav - 1000 mg twice daily 10 days for the empiric treatment of ABS in outpatient clinic practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin SR | Azithromycin SR, 2.0 g by mouth (PO) x 1 |
| DRUG | Amoxiclav 1000 mg | Amoxiclav 1000 mg x twice daily, 10 days |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2009-12-15
- Last updated
- 2012-04-16
- Results posted
- 2012-03-22
Source: ClinicalTrials.gov record NCT01032174. Inclusion in this directory is not an endorsement.